Paula Wittmann-Hoffmeister
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Sacituzumab govitecan in colorectal cancer: clinical evidence and future directions.
Journal: Future oncology (London, England)
Published: May 27, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Optimization of multiprofessional care for young colorectal cancer patients: a qualitative Study.
Journal: The oncologist
Published: November 05, 2024
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer.
Journal: Radiation oncology (London, England)
Published: September 20, 2024
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 21, 2024
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.
Journal: JHEP reports : innovation in hepatology
Published: November 10, 2023
Bcl-xL as prognostic marker and potential therapeutic target in cholangiocarcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 11, 2022
Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC.
Journal: Hepatology (Baltimore, Md.)
Published: December 21, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026